DAY 4 - Wednesday, May 9
RETINA
Transchoroidal implant surgery for RP successful
Fort Lauderdale, FL—Implantation of a new transchoroidal artificial device for patients with retinitis pigmentosa (RP) provides blind patients with visual abilities and vision that does not fade, said Helmut Sachs, MD, who described the results achieved with 20 patients. » MORE
New OCT parameters associated with wet AMD risk
Fort Lauderdale, FL—Although optical coherence tomography (OCT) is widely used in the diagnosis and management of age-related macular degeneration (AMD), closer scrutiny of these scans may reveal useful new parameters, according to Florian M. Heussen, MD. » MORE
Vitrectomy provides relief from severe floaters
Fort Lauderdale, FL—Patients with severe floaters had marked improvements in visual acuity and quality of life after undergoing vitrectomy to remove vitreous floaters and debris, according to John O. Mason III, MD. » MORE
Ocriplasmin promising option in VMA subgroup
Fort Lauderdale, FL—Pharmacologic vitreolysis with a single intravitreal injection of 125 µg of ocriplasmin (ThromboGenics) resulted in vitreomacular adhesion (VMA) resolution at day 28 in about 30% of patients, and up to 40% in those with smaller zones of adhesion, compared with 7.7% in a placebo-treated group in a subgroup responder analysis of phase III MIVI-TRUST clinical trial data, said Baruch D. Kupperman, MD, PhD. » MORE
Axonal regeneration in monkey retina present through life
Fort Lauderdale, FL—Regeneration of retinal axons continues throughout life in monkey retinas, but the ability to regenerate is stronger in younger animals. Using in vitro culture models, Solon Thanos, MD, PhD, discussed the molecular mechanisms involved in regeneration of monkey retinal ganglion cell axons in retinal cultures in vitro. » MORE
CORNEA
DMEK graft rejection lowest among transplant techniques
Fort Lauderdale, FL—The 2-year immunologic graft rejection rate for Descemet’s membrane endothelial keratoplasty (DMEK) was the lowest among four types of cornea transplants used for treatment of endothelial dysfunction in a single-center study, said Marianne O. Price, PhD. » MORE
GLAUCOMA
Vitamin B12: Neuroprotectant against optic neuropathy?
Fort Lauderdale, FL—Cyanocobalamin, the most abundant form of vitamin B12, might be a neuroprotectant that potentially could also be used as a therapy to slow retinal ganglion cell (RGC) death in patients with optic neuropathies characterized by overproduction of superoxide, said Wesley Chan, MSc. » MORE
LOW VISION
Bioptic telescope users rate high on driving safety test
Fort Lauderdale, FL—Despite moderate central vision loss, 96% of drivers who used a bioptic telescope were rated safe to drive following an on-road driving performance test. These findings may guide the assessment and training of bioptic drivers and allow more of them to maintain independence, employment, and mobility within their communities, said Joanne M. Wood, PhD. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
